Drugs / Zinc Sulfate
Zinc Sulfate
also known as
Zinc · zinc sulphate · Zinc acetate · Zinc citrate · Zinc Chloride · NPC-02 · ZnCl2 · Galzin (zinc acetata, Teva Pharmaceuticals) · +6 more
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | ZINC CHLORIDE IN PLASTIC CONTAINER | — | 1986-06-26 | fda.gov ↗ |
Trials 126 · started per year
today
US approved 1986
1
2
1
1
2
1
2
5
7
6
8
5
4
3
7
2
2
3
4
4
3
1
2
4
6
10
3
4
8
5
9
1986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT05680662 | Jan → Dec 2023 | female breast carcinoma, triple-negative breast carcinoma | Ministry of Health, Saudi Arabia | Unknown | No outcome recorded |
| Phase 0 | NCT05178953 | Aug 2021 → Jan 2022 | male infertility | Arak University of Medical Sciences | Unknown | No outcome recorded |
| Phase 15 trials | ||||||
| Phase 1 | NCT05116098 | Nov 2021 → Jun 2022 | tuberculosis | Ministry of Health, Saudi Arabia | Unknown | No outcome recorded |
| Phase 1 | NCT03690583 | Jan 2014 → Feb 2016 | pneumonia | Universidad Nacional Autonoma de Mexico | Completed | No outcome recorded |
| Phase 1 | NCT00696410 | Jun 2008 → Jun 2011 | cardiomyopathy, heart failure | University of Michigan | Completed | No outcome recorded |
| Phase 1 | NCT01062347 | Jul 2007 → Dec 2010 | disorder of zinc metabolism | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| Phase 1 | NCT00278681 | Aug 2003 → Aug 2004 | acute diarrhea | Society for Applied Studies | Completed | No outcome recorded |
| Phase 1/23 trials | ||||||
| Phase 1/2 | NCT01662089 | Jan → Oct 2012 | androgenetic alopecia | Siriraj Hospital | Unknown | No outcome recorded |
| Phase 1/2 | NCT01259050 | Oct 2010 → Jan 2012 | amyotrophic lateral sclerosis | Phoenix Neurological Associates, LTD | Completed | No outcome recorded |
| Phase 1/2 | NCT01019083 | Feb 2008 → Dec 2010 | cholera, typhoid fever | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| Phase 220 trials · 2 missed | ||||||
| Phase 2 | NCT07793695 | Sep 2026 → Aug 2027 expected | hepatocellular carcinoma | Anhui Provincial Hospital | Recruiting | No outcome recorded |
| Phase 2 | NCT07140874 | Jun 2026 → May 2027 expected | cervical dystonia | University of Florida | Recruiting | No outcome recorded |
| Phase 2 | NCT07405554 | Feb → Dec 2026 expected | overactive bladder | Endeavor Health | Recruiting | No outcome recorded |
| Phase 2 | NCT06260891 | Feb 2026 → Jul 2027 expected | sickle cell disease | University of California, San Francisco | Recruiting | No outcome recorded |
| Phase 2 | NCT06567717 | Nov 2025 → Jan 2027 expected | idiopathic pulmonary fibrosis | Cedars-Sinai Medical Center | Recruiting | No outcome recorded |
| Phase 2 | NCT07102836 | Aug 2025 → Feb 2026 overdue | hyperbilirubinemia | Quaid-e-Azam Medical College | Recruiting | No outcome recorded |
| Phase 2 | NCT06412653 | Aug 2024 → Aug 2025 | developmental and epileptic encephalopathy, 17, developmental disability, dystonic disorder, neurodevelopmental disorder with involuntary movements | Children's University Hospital Cologne, Germany | Completed | No outcome recorded |
| Phase 2 | NCT06482034 | Jun 2023 → Sep 2024 | mucositis | Mansoura University | Completed | No outcome recorded |
| Phase 2 | NCT04898023 | Sep 2022 → Oct 2023 | viral respiratory tract infection | University of Missouri-Columbia | Terminated | No outcome recorded Stop: Business |
| Phase 2 | NCT05395143 | May 2021 → Jul 2022 | hyperlipidemia | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Unknown | No outcome recorded |
| Phase 2 | NCT02421887 | Dec 2015 → Jun 2018 | male infertility | Yale University | Completed | Missed primary |
| Phase 2 | NCT03159845 | Jan 2014 → Sep 2019 | disease related to hematopoietic stem cell transplant | Azienda Ospedaliero, Universitaria Pisana | Completed | No outcome recorded |
| Phase 2 | NCT02062034 | Feb 2011 → Nov 2013 | diabetic retinopathy, type 2 diabetes mellitus | University of Guadalajara | Completed | No outcome recorded |
| Phase 2 | NCT01140074 | Jul 2010 → Jun 2012 | acute diarrhea | University Hospital No 1 Wroclaw | Unknown | No outcome recorded |
| Phase 2 | NCT00878605 | Apr 2010 → Jun 2013 | type 2 diabetes mellitus | VA Office of Research and Development | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT02101008 | Mar 2010 → Feb 2013 | melanoma | University of Utah | Completed | No outcome recorded |
| Phase 2 | NCT00683644 | Jan 2008 → Dec 2011 | tinnitus | University of Iowa | Completed | Missed primary |
| Phase 2 | NCT00963131 | Dec 2004 → Dec 2008 | central serous chorioretinopathy | Prince of Songkla University | Completed | No outcome recorded |
| Phase 2 | NCT00138047 | Mar 2003 → Sep 2004 | HIV infectious disease | Johns Hopkins Bloomberg School of Public Health | Completed | No outcome recorded |
| Phase 2 | NCT00133419 | ? → Jan 2006 | intestinal infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 2/311 trials · 1 met primary · 4 missed | ||||||
| Phase 2/3 | NCT06561061 | Feb → Nov 2025 | sickle cell disease | Indiana University | Completed | No outcome recorded |
| Phase 2/3 | NCT04959786 | Apr 2021 → Nov 2022 | pneumonia | Mansoura University | Unknown | No outcome recorded |
| Phase 2/3 | NCT04301336 | Nov 2019 → Nov 2020 | sickle cell disease | Beni-Suef University | Completed | No outcome recorded |
| Phase 2/3 | NCT02868151 | Aug 2016 → Dec 2017 | mucositis | Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre | Completed | No outcome recorded |
| Phase 2/3 | NCT04574544 | Mar → Dec 2015 | — | University of Douala | Completed | No outcome recorded |
| Phase 2/3 | NCT01809132 | Sep 2013 → Oct 2018 | alcoholic hepatitis | Mack Mitchell | Completed | Missed primary |
| Phase 2/3 | NCT01015183 | Nov 2009 → Nov 2010 | mucositis | Tehran University of Medical Sciences | Completed | No outcome recorded |
| Phase 2/3 | NCT00252304 | Jan 2006 → Jul 2008 | pneumonia | Centre For International Health | Completed | Missed primary |
| Phase 2/3 | NCT00347386 | Jul 2005 → Dec 2008 | infectious disease with sepsis, pneumonia, primary bacterial infectious disease | Centre For International Health | Completed | Met primary |
| Phase 2/3 | NCT00148733 | Jan 2004 → Jan 2008 | pneumonia | Centre For International Health | Completed | Missed primary |
| Phase 2/3 | NCT00370968 | Sep 2003 → Dec 2006 | acute diarrhea | Centre For International Health | Completed | Missed primary |
| Phase 332 trials · 2 met primary · 7 missed | ||||||
| Phase 3 | NCT07664592 | Jun → Jul 2026 overdue | dentin sensitivity | Colgate Palmolive | Recruiting | No outcome recorded |
| Phase 3 | NCT07398378 | Jun → Jul 2026 overdue | mouth disorder | Colgate Palmolive | Active not recruiting | No outcome recorded |
| Phase 3 | NCT06433674 | Jun 2024 → Jul 2025 | nutritional deficiency disease | University of Tennessee | Unknown | No outcome recorded |
| Phase 3 | NCT05614349 | Jan 2023 → Apr 2025 overdue | COVID-19 | Unity Health Toronto | Active not recruiting | Missed primary |
| Phase 3 | NCT06479226 | Jun → Oct 2022 | — | Colgate Palmolive | Completed | No outcome recorded |
| Phase 3 | NCT06869798 | Sep 2021 → Oct 2022 | childhood onset asthma | King Edward Medical University | Completed | Met primary |
| Phase 3 | NCT04447534 | Jun → Jul 2020 | COVID-19 | Tanta University | Completed | Missed primary |
| Phase 3 | NCT04446104 | May → Aug 2020 | COVID-19 | National University Hospital, Singapore | Completed | No outcome recorded |
| Phase 3 | NCT06227624 | Jun 2018 → Jun 2019 | congenital nonhemolytic jaundice | National Liver Institute, Egypt | Completed | No outcome recorded |
| Phase 3 | NCT03824925 | Dec 2016 → Oct 2018 | oral sensibility, disturbance of | Dow University of Health Sciences | Completed | No outcome recorded |
| Phase 3 | NCT02321865 | Jan → Nov 2015 | disorder of zinc metabolism | Nobelpharma | Completed | No outcome recorded |
| Phase 3 | NCT02337569 | Jan → Nov 2015 | disorder of zinc metabolism | Nobelpharma | Completed | No outcome recorded |
| Phase 3 | NCT00801606 | Dec 2008 → Jun 2012 | tuberculosis | All India Institute of Medical Sciences | Completed | Missed primary |
| Phase 3 | NCT00530829 | Oct 2007 → Apr 2009 | diarrheal disease | Centers for Disease Control and Prevention | Completed | Missed primary |
| Phase 3 | NCT00421668 | Sep 2007 → Oct 2012 | diarrheal disease, respiratory tract infectious disorder | Harvard School of Public Health (HSPH) | Completed | No outcome recorded |
| Phase 3 | NCT00395161 | Apr 2007 → Nov 2009 | infectious disease with sepsis | Michael Dean | Terminated | Missed primary |
| Phase 3 | NCT00373100 | Sep 2006 → Mar 2007 | pneumonia | Makerere University | Completed | Missed primary |
| Phase 3 | NCT00133406 | Jun 2006 → Dec 2011 | diarrheal disease | University of Virginia | Unknown | No outcome recorded |
| Phase 3 | NCT00536133 | Apr 2006 → May 2008 | respiratory tract infectious disorder | Jawaharlal Nehru Medical College | Completed | No outcome recorded |
| Phase 3 | NCT00355043 | Feb 2006 → Sep 2007 | bronchiolitis | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| Phase 3 | NCT00133432 | Sep 2005 → ? | pneumonia | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded |
| Phase 3 | NCT00212355 | Mar 2005 → Apr 2008 | Wilson disease | Nobelpharma | Completed | No outcome recorded |
| Phase 3 | NCT00325247 | Feb 2005 → May 2006 | acute diarrhea | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| Phase 3 | NCT00408356 | Nov 2004 → Aug 2006 | acute diarrhea | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| Phase 3 | NCT00142285 | Nov 2004 → May 2006 | pneumonia | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| Phase 3 | NCT00212368 | Oct 2004 → Aug 2005 | Wilson disease | Nobelpharma | Completed | No outcome recorded |
| Phase 3 | NCT00098202 | Mar 2003 → Apr 2007 | pregnancy disorder | NICHD Global Network for Women's and Children's Health | Completed | No outcome recorded |
| Phase 3 | NCT00255385 | Apr 2002 → Apr 2004 | diarrheal disease, pneumonia | Johns Hopkins Bloomberg School of Public Health | Completed | Mixed |
| Phase 3 | NCT00109551 | Oct 2001 → Jan 2006 | — | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Completed | Missed primary |
| Phase 3 | NCT00226616 | Nov 2000 → Jul 2002 | cholera | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | Met primary |
| Phase 3 | NCT00321126 | Jan 1999 → Apr 2002 | — | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| Phase 3 | NCT01437826 | Mar 1988 → Jun 1996 | colorectal adenoma | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | Terminated | No outcome recorded |
| Phase 415 trials · 1 met primary | ||||||
| Phase 4 | NCT07807397 | Sep 2026 → Sep 2027 expected | dental caries, gingivitis | Colgate Palmolive | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06517862 | Sep 2024 → Mar 2026 | hyperbilirubinemia | Amira Adel Fouly | Completed | No outcome recorded |
| Phase 4 | NCT05190562 | Sep 2021 → Jan 2022 | geographic tongue | mariam hamouda | Completed | No outcome recorded |
| Phase 4 | NCT04621461 | Dec 2020 → Feb 2021 | COVID-19 | St. Francis Hospital, New York | Completed | No outcome recorded |
| Phase 4 | NCT04468139 | Jun → Jul 2020 | COVID-19 | Ministry of Health, Saudi Arabia | Unknown | No outcome recorded |
| Phase 4 | NCT04370782 | Apr → Sep 2020 | COVID-19 | St. Francis Hospital, New York | Completed | No outcome recorded |
| Phase 4 | NCT04278599 | Jan → Sep 2020 | lichen planus, oral | Postgraduate Institute of Dental Sciences Rohtak | Unknown | No outcome recorded |
| Phase 4 | NCT05002101 | Aug 2018 → Aug 2019 | disorder of zinc metabolism, nutritional disorder | Ain Shams University | Completed | Met primary |
| Phase 4 | NCT03098810 | Apr → Sep 2017 | eating disorder | Ain Shams University | Unknown | No outcome recorded |
| Phase 4 | NCT05311540 | Mar 2014 → Mar 2015 | disorder of zinc metabolism | Zekai Tahir Burak Women's Health Research and Education Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03117192 | Sep 2013 → Feb 2014 | thalassemia | Faculty of Medicine, University of Indonesia | Completed | No outcome recorded |
| Phase 4 | NCT01475227 | Dec 2011 → Mar 2012 | HIV infectious disease | St Stephens Aids Trust | Completed | No outcome recorded |
| Phase 4 | NCT00449592 | Apr 2007 → Sep 2008 | mucositis | Sheba Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT00228254 | Jan 2000 → Jun 2004 | diarrheal disease, pneumonia | Tufts University | Completed | No outcome recorded |
| Phase 4 | NCT00004338 | Oct 1993 → ? | Wilson disease | National Center for Research Resources (NCRR) | Completed | No outcome recorded |
| Phase not applicable38 trials · 6 missed | ||||||
| — | NCT07509918 | Sep → Oct 2026 expected | — | Cairo University | Not yet recruiting | No outcome recorded |
| — | NCT07538999 | Apr 2026 → Dec 2027 expected | — | Children's Hospital of Fudan University | Recruiting | No outcome recorded |
| — | NCT07383363 | Sep 2025 → Mar 2026 | autism spectrum disorder | Muhammad Aamir Latif | Completed | No outcome recorded |
| — | NCT07169188 | Sep → Dec 2025 | gingivitis | HALEON | Completed | No outcome recorded |
| — | NCT06673082 | Dec 2024 → Apr 2025 overdue | food protein-induced allergic proctocolitis | Kasr El Aini Hospital | Enrolling by invitation | No outcome recorded |
| — | NCT06602466 | Sep → Dec 2024 | gingivitis | HALEON | Completed | Missed primary |
| — | NCT06847139 | Jul 2024 → Jul 2025 overdue | chronic kidney disease | Chittagong Medical College | Recruiting | No outcome recorded |
| — | NCT06556511 | Feb → May 2024 | infectious disease with sepsis | dr. Aldora Jesslyn Oentari | Completed | No outcome recorded |
| — | NCT06860620 | Jan → Dec 2024 | nephrotic syndrome of childhood - steroid sensitive | Muhammad Aamir Latif | Completed | No outcome recorded |
| — | NCT06042010 | Jan → Feb 2023 | lichen planus, oral | Hams Hamed Abdelrahman | Completed | No outcome recorded |
| — | NCT05156684 | Jan 2022 | infertility disorder | Arak University of Medical Sciences | Unknown | No outcome recorded |
| — | NCT05161611 | Dec 2021 → Aug 2022 | hyperbilirubinemia | Makassed General Hospital | Completed | No outcome recorded |
| — | NCT04935515 | Apr → May 2021 | COVID-19 | Manimarane Arjunan, MD,DM (Cardiology) | Completed | No outcome recorded |
| — | NCT05543603 | Apr 2021 → Jan 2022 | COVID-19 | FISABIO Foundation | Completed | No outcome recorded |
| — | NCT06042738 | Mar → Nov 2021 | male infertility | Ondokuz Mayıs University | Completed | No outcome recorded |
| — | NCT04039828 | Sep 2019 → Mar 2020 | acute diarrhea | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| — | NCT04321850 | Jun 2019 → Jun 2020 | chemotherapy-induced oral mucositis | National Institute of Pediatrics, Mexico | Terminated | No outcome recorded |
| — | NCT03923829 | Apr 2019 → Aug 2020 | chronic periodontitis | Cairo University | Unknown | No outcome recorded |
| — | NCT03293641 | May 2016 → Jan 2017 | disorder of zinc metabolism, infectious disease, sickle cell disease | Lucas Otieno Tina, MD MSc | Completed | No outcome recorded |
| — | NCT02351687 | Apr 2014 → Jun 2016 | protein-energy malnutrition | Washington University School of Medicine | Completed | Missed primary |
| — | NCT01857310 | Jun 2013 → Jun 2019 | pregnancy disorder with abortive outcome | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Completed | Missed primary |
| — | NCT01546805 | Apr → Dec 2012 | benign essential blepharospasm, clonic hemifacial spasm | St. Joseph's Healthcare Hamilton | Unknown | No outcome recorded |
| — | NCT01198587 | Nov 2010 → Jun 2014 | acute diarrhea, gastroenteritis | Boston Children's Hospital | Completed | Missed primary |
| — | NCT01229579 | May 2010 → Jan 2011 | poliomyelitis | Aga Khan University | Completed | No outcome recorded |
| — | NCT01474486 | Apr 2010 → Feb 2016 | cardiomyopathy, congestive heart failure | Phoenix VA Health Care System | Completed | No outcome recorded |
| — | NCT01069198 | Oct 2009 → Oct 2010 | visceral leishmaniasis | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| — | NCT01306097 | Jan 2009 → Jan 2010 | diarrheal disease | Hormozgan University of Medical Sciences | Completed | No outcome recorded |
| — | NCT00395226 | Jul 2006 → Jul 2008 | rosacea | Essentia Health | Terminated | Missed primary Stop: Enrollment |
| — | NCT00394862 | Jan → Jun 2006 | neural tube defect | Emory University | Completed | No outcome recorded |
| — | NCT00272142 | Jan 2005 → Aug 2007 | diarrheal disease, fetal growth restriction, respiratory tract infectious disorder | Society for Applied Studies | Completed | No outcome recorded |
| — | NCT00278746 | Jan 2005 → Sep 2006 | acute diarrhea | Society for Applied Studies | Completed | No outcome recorded |
| — | NCT00104494 | May 2004 → Sep 2007 | cystic fibrosis | Cystic Fibrosis Foundation | Completed | No outcome recorded |
| — | NCT00399256 | Mar 2004 → Mar 2006 | chronic renal failure syndrome | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) | Terminated | No outcome recorded |
| — | NCT00198666 | Sep 2003 → Aug 2004 | pneumonia | Johns Hopkins Bloomberg School of Public Health | Completed | No outcome recorded |
| — | NCT00269542 | Feb 2002 → Mar 2003 | diarrheal disease, pneumonia | Society for Applied Studies | Completed | No outcome recorded |
| — | NCT00272116 | Feb 1998 → Feb 2000 | diarrheal disease, pneumonia | Society for Applied Studies | Completed | No outcome recorded |
| — | NCT00374023 | Jul 1993 → Nov 1995 | diarrheal disease, respiratory tract infectious disorder | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| — | NCT00378456 | — | trisomy 21 | Institute of Child Health | Completed | Missed primary |
| Comparator or background therapy43 trials | ||||||
| Phase 0 | NCT06588036 Comparator | Sep → Dec 2024 overdue | — | Combined Military Hospital Multan | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT05670444 Comparator | Jan → Feb 2023 | influenza | Hôpital Universitaire Sahloul | Completed | No outcome recorded |
| Phase 1 | NCT05104424 Comparator | Dec 2021 → Aug 2022 | olfactory nerve disorder, oral sensibility, disturbance of | Ministry of Health, Saudi Arabia | Unknown | No outcome recorded |
| Phase 1 | NCT00325572 Comparator | Nov 2006 → Dec 2010 | autism spectrum disorder | Milton S. Hershey Medical Center | Terminated | No outcome recorded |
| Phase 1/2 | NCT05453227 Comparator | Dec 2021 → Dec 2022 | — | Egymedicalpedia | Completed | No outcome recorded |
| Phase 1/2 | NCT04472585 Comparator | Nov 2020 → Aug 2021 | COVID-19 | Sohaib Ashraf | Unknown | No outcome recorded |
| Phase 1/2 | NCT04591600 Background | Jul → Sep 2020 | COVID-19 | Alkarkh Health Directorate-Baghdad | Completed | No outcome recorded |
| Phase 1/2 | NCT01062009 Comparator | Nov 2008 → Oct 2014 | — | UCSF Benioff Children's Hospital Oakland | Completed | No outcome recorded |
| Phase 2 | NCT07145268 Comparator | Sep 2025 → Sep 2026 overdue | fibrotic liver disease, hepatitis B virus infection | Tanta University | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT05398965 Background | Nov 2020 → Jan 2021 | COVID-19 | Hasanuddin University | Completed | No outcome recorded |
| Phase 2 | NCT04072822 Comparator | Jul 2020 → May 2022 | alcoholic hepatitis | Indiana University | Completed | No outcome recorded |
| Phase 2 | NCT05366595 Comparator | Jul 2019 → Jun 2022 | — | Mansoura University | Completed | No outcome recorded |
| Phase 2 | NCT03135522 Comparator | Feb 2018 → Dec 2019 | — | Johns Hopkins University | Completed | No outcome recorded |
| Phase 2 | NCT02058212 Comparator | Mar → Oct 2013 | endometriosis | Cairo University | Completed | No outcome recorded |
| Phase 2 | NCT01210014 Comparator | Apr 2008 → Apr 2009 | aphthous stomatitis | Qazvin University Of Medical Sciences | Completed | No outcome recorded |
| Phase 2 | NCT00210470 Background | Jul 2005 → Dec 2010 | head and neck squamous cell carcinoma | Brooklyn ImmunoTherapeutics, LLC | Completed | No outcome recorded |
| Phase 2/3 | NCT05463484 Comparator | Jul 2021 → Feb 2023 | mouth disorder | Mucosa Innovations, S.L. | Completed | No outcome recorded |
| Phase 3 | NCT07848100 Comparator | Oct 2026 → Oct 2027 expected | human papilloma virus infection, plantar wart | Assiut University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07275827 Comparator | Feb → Dec 2026 expected | Helicobacter pylori infectious disease | Tanta University | Recruiting | No outcome recorded |
| Phase 3 | NCT05465434 Comparator | Aug 2022 → Jan 2023 | chronic hepatitis C virus infection | Tanta University | Completed | No outcome recorded |
| Phase 3 | NCT05047523 Comparator | Sep 2021 → Jun 2023 | Wilson disease | Alexion Pharmaceuticals, Inc. | Terminated | No outcome recorded Stop: Business |
| Phase 3 | NCT04189367 Background | Jun 2020 → Jul 2022 | burning mouth syndrome | Chang Gung Memorial Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT04810728 Background | Jun → Dec 2020 | COVID-19 | Baiturrahmah University | Completed | Met primary |
| Phase 3 | NCT04377646 Comparator | May 2020 | COVID-19 | Military Hospital of Tunis | Unknown | No outcome recorded |
| Phase 3 | NCT03158168 Comparator | Mar 2018 → Jun 2019 | skin disorder caused by infection | Assiut University | Unknown | No outcome recorded |
| Phase 3 | NCT03403205 Comparator | Feb 2018 → Jun 2023 | Wilson disease | Alexion Pharmaceuticals, Inc. | Terminated | Met primary Stop: Business |
| Phase 3 | NCT03851055 Comparator | Aug 2017 → Jul 2018 | beta-thalassemia major | Ain Shams University | Completed | No outcome recorded |
| Phase 3 | NCT02714543 Comparator | Nov 2013 → Aug 2015 | oral submucous fibrosis | The Oxford Dental College, Hospital and Research Center, Bangalore, India | Completed | No outcome recorded |
| Phase 4 | NCT07862725 Background | Oct 2026 → Oct 2027 expected | oligoasthenoteratozoospermia | Hamad Medical Corporation | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07758335 Comparator | Jul 2025 → Mar 2027 expected | ulcerative colitis | National Hepatology & Tropical Medicine Research Institute | Recruiting | No outcome recorded |
| Phase 4 | NCT05677126 Comparator | Aug 2024 | — | American Regent, Inc. | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT06151392 Comparator | Jul 2023 → Dec 2025 overdue | infectious disorder of the nervous system | Ain Shams University | Recruiting | No outcome recorded |
| Phase 4 | NCT04050488 Comparator | Aug 2019 → Jul 2020 | bronchopulmonary dysplasia, fetal growth restriction, necrotizing enterocolitis, neonatal sepsis +1 | Faculty of Medicine, University of Indonesia | Unknown | No outcome recorded |
| Phase 4 | NCT03005496 Comparator | Jan → Apr 2017 | — | Indonesia University | Completed | No outcome recorded |
| Phase 4 | NCT01571856 Comparator | Jul 2011 → Jul 2012 | acute diarrhea, gastroenteritis | Centro Pediatrico Albina de Patino | Completed | No outcome recorded |
| Phase 4 | NCT00431691 Comparator | Sep 2006 → Dec 2007 | escherichia coli infection, retinal disorder | Medical University of Vienna | Completed | No outcome recorded |
| — | NCT06009744 Comparator | Aug 2023 → Dec 2028 expected | intestinal fistula | Hospital Juarez de Mexico | Recruiting | No outcome recorded |
| — | NCT06540209 Background | Apr → Sep 2023 | acute diarrhea | RESnTEC, Institute of Research | Completed | No outcome recorded |
| — | NCT05930002 Comparator | Jul 2021 → Sep 2022 | COVID-19 | Ain Shams University | Completed | No outcome recorded |
| — | NCT04482296 Comparator | Sep 2019 → Jul 2020 | major depressive disorder | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Completed | No outcome recorded |
| — | NCT00914576 Comparator | Apr 2011 → Jul 2013 | — | Medical University of Vienna | Completed | No outcome recorded |
| — | NCT01101217 Comparator | Feb → Sep 2009 | end stage renal failure | Shiraz University of Medical Sciences | Completed | No outcome recorded |
| — | NCT00682955 Comparator | Aug 2007 → Apr 2008 | acute diarrhea | Aga Khan University | Completed | No outcome recorded |
Evidence & citations 18 cited values
Every value below carries the sentence it was read from. 173 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | zinc sulfate | “The intervention was delivered most commonly in the form of syrup as zinc sulfate, and the most common dose was between 10 mg and 15 mg daily.” PMID 36994923 ↗ Mar 202339“The intervention was delivered most commonly in the form of syrup as zinc sulfate, and the most common dose was between 10 mg and 15 mg daily.” PMID 36994923 ↗ Mar 2023 “daily zinc sulfate (20 mg/day) for two weeks prior to immunization and until the last follow-up for sample collection” NCT01019083 ↗ “50 mg/day of zinc sulfate in addition to the standard direct-acting antiviral therapy for the same duration.” PMID 39789197 ↗ Jan 2025 “Zinc Sulfate (Zn SO4) one tablet daily at bedtime which provides 50 mg elemental zinc (220 mg Zn SO4)” NCT01474486 ↗ “Zinc Sulfate Tablets” NCT03293641 ↗ |
| Known as | Galzin (zinc acetata, Teva Pharmaceuticals) | “Galzin (zinc acetata, Teva Pharmaceuticals)” NCT00696410 ↗ |
| Known as | NPC-02 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02337569 ↗ |
| Known as | Solvazinc | “Zinc sulphate 125mg (1 Solvazinc tablet) once daily orally after dissolution in water, day 2 to day 15” NCT01475227 ↗ |
| Known as | Zinc | “This standard treatment is personalized according to the severity but is not limited to standard antiviral therapy, azithromycin 500 mg a day, vitamin C 500 mg 8 hourly a day,...” NCT05398965 ↗102“food supplement containing 2000 mg L-carnitine, 2000 mg fructose, 932 mg acetyl L-carnitine, 225 mg vitamin C, 115 mg citric acid, 50 mg coenzyme Q10, 14 mg zinc, 115 µg...” NCT06042738 ↗ “Depending on the site/region, participants randomized to receive Standard of Care treatment will receive trientine, penicillamine, zinc, or a combination of these medicines,...” NCT05047523 ↗ “a Cyclo-Z capsule containing Cyclo-His Pro (CHP) 0 (placebo), 3 mg (minimally effective), 9 mg (optimally effective), or 15 mg (no-additional effect) plus 20 mg zinc on...” NCT00878605 ↗ “Depending on the site/region, participants randomized to receive SoC treatment will receive trientine, penicillamine, Zinc, or a combination of these medicines, administered...” NCT03403205 ↗ “Tablet: Vitamin C, 500 mg; Vitamin D3, 1000 IU; Vitamin E, 400 IU; Folic Acid 1000 mcg; Zinc, 20 mg; Selenium 200 mcg; Lycopene, 10 mg; Capsule: Vitamin D3, 1000 IU,...” NCT02421887 ↗ “The second therapeutic arm investigates a combination antioxidant therapy (selenium 300 µg, zinc 40 mg, lycopene 45 mg and vitamin C 1.5 g), administered for 10 days.” PMID 40754325 ↗ Aug 2025 “(1 mg copper, 20 mg zinc, 180 mg vitamin C, 30 mg vitamin E, 1 mg zeaxanthin, 4 mg astaxanthin, 10 mg lutein) daily of oral, all of them in one Tablet for 24 weeks” NCT02062034 ↗ “Participants will receive antioxidant therapy consisting of vitamin C 1000 mg/day, vitamin E 400 IU/day, L-carnitine, and zinc 25 mg/day for 6 months.” NCT07862725 ↗ “The treatment group received two pills in the morning containing Vit C Vit D zinc and minerals and one pill of 2 mg of melatonin in the evening” NCT05670444 ↗ “Nutritional supplement: vitamin B12, folic acid, iron, zinc, vitamin B complex depending on the hematic deficiency, for 12 weeks” NCT04189367 ↗ |
| Known as | Zinc acetate | “In this study, the authors used zinc acetate to treat Japanese patients with Wilson disease and investigated its efficacy.” PMID 21078496 ↗ Sep 2010 |
| Known as | Zinc Acetate Dihydrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06412653 ↗ |
| Known as | Zinc Chloride | “0.454% Stannous Fluoride, 0.3% Zinc Chloride,1% Alumina toothpaste containing 1100 parts per million (ppm) fluoride.” NCT06602466 ↗2“Toothpaste containing 0.454% SnF2, 0.3% zinc chloride (ZnCl2) and 1% alumina.” NCT07169188 ↗ “15 ml 0,10% cymenol + 0,10% zinc chloride, one minute rinse” NCT05543603 ↗ |
| Known as | Zinc citrate | “Compounded capsules containing each zinc citrate, green tea extract, and ascorbic acid.” NCT04898023 ↗4“Commercial Fluoridated toothpaste for gingivitis with zinc citrate.” NCT05463484 ↗ “Drug: Zinc citrate” NCT07140874 ↗ “0.5% zinc citrate” NCT07398378 ↗ |
| Known as | Zinc Phosphate | “A commercially available fluoride toothpaste containing 8% arginine + Zinc Phosphate” NCT07664592 ↗ |
| Known as | Zinc Sulfate, generic | “Zinc Sulfate, generic” NCT01809132 ↗ |
| Known as | zinc sulphate | “SM Fibro (Alpha lipoic acid 50mg, Beta-carotene 10mg, Elemental copper 1mg, Elemental selenium 75mcg, Lycopene 5mg, Vitamin E 10 IU, Zinc sulphate 27.45mg in form of the...” NCT02714543 ↗15“second group (n = 27) was on OHA and in addition 50 mg elemental zinc as zinc sulphate supplementation for 12 weeks” PMID 24082728 ↗ Jul 2013 “The 25 supplemented children had received an oral dose of 10 mg of zinc sulphate per day for 14 days” NCT04574544 ↗ “Zinc sulphate 125mg, day 2 to day 15” NCT01475227 ↗ “Drug: Zinc (zinc sulphate)” NCT00347386 ↗ “Zinc (zinc sulphate)” NCT07145268 ↗ “Zinc (zinc sulphate)” NCT00252304 ↗ “Drug: zinc sulphate” NCT06869798 ↗ “Zinc sulphate 50 mg” NCT05465434 ↗ |
| Known as | Zn SO4 | “Zinc Sulfate (Zn SO4) one tablet daily at bedtime which provides 50 mg elemental zinc (220 mg Zn SO4)” NCT01474486 ↗ |
| Known as | Zn sulfate | “Neonates will receive oral Zn sulfate solution in either low doses (10 mg/day) or high doses (20 mg/day) given twice daily.” NCT06517862 ↗ |
| Known as | ZnCl2 | “0.454 percent (%) Stannous Fluoride (SnF2), 0.3% Zinc Chloride (ZnCl2) and 1% Alumina” NCT06602466 ↗1“Toothpaste containing 0.454% SnF2, 0.3% zinc chloride (ZnCl2) and 1% alumina.” NCT07169188 ↗ |
| Action | Activate | “MTT is an endogenous antioxidant that can be induced by both zinc (Zn) and ischemia.” PMID 28302075 ↗ Mar 2017 |
| Modality | Other / unclassified | “micronutrients (especially of zinc and iron)” PMID 20730057 ↗ Aug 2010 |
| Route | Oral | “They will be instructed to take 1 mL of the solution twice daily for two months.” NCT00104494 ↗ |